Retinopathy of prematurity (ROP) is a significant cause of potentially preventable blindness
in preterm infants worldwide. It is a disease caused by abnormal retinal vascularization that …

The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

Importance Laser photocoagulation, which is the standard treatment for retinopathy of
prematurity (ROP), can have adverse events. Studies of anti–vascular endothelial growth …

BACKGROUND Mortality and morbidity for very preterm infants in the United States
decreased for years. The current study describes recent changes to assess whether the …

Topic To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary
therapies for retinopathy of prematurity (ROP) in terms of retreatment rate. Clinical relevance …

Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina and a leading
cause of visual impairment and childhood blindness worldwide. The disease is …

Retinopathy of prematurity (ROP) is a devastating neurovascular disease of the retina in
newborn infants that can lead to vision deficits or even blindness. In this concise review we …

Retinopathy of prematurity (ROP) is a rare proliferative ocular disorder in preterm infants.
Because of the advancements in neonatal care, the incidence of ROP has increased …

Importance Retinopathy of prematurity (ROP) is a leading cause of preventable blindness
that disproportionately affects children born in low-and middle-income countries (LMICs). In …

Retinopathy of prematurity (ROP) is a leading cause of preventable vision loss in preterm
infants. While appropriate screening is crucial for early identification and treatment of ROP …